Search research articles
Contact Us
Filters
Showing results (541-550 of 664) with videos related to
Page
of 67
Sort By:
British Journal of Haematology
|
April 16, 2022
Donor-transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation
Susanne Ghandili, Malte A Kluger, Theo Leitner, et al.
BMC Cancer
|
June 4, 2020
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)
Joseph Tintelnot, Eray Goekkurt, Mascha Binder, et al.
Marine Drugs
|
March 28, 2023
New Bioactive β-Resorcylic Acid Derivatives from the Alga-Derived Fungus <i>Penicillium antarcticum</i> KMM 4685
Elena V Leshchenko, Alexandr S Antonov, Gleb V Borkunov, et al.
The New England Journal of Medicine
|
September 12, 2008
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B Vermorken, Ricard Mesia, Fernando Rivera, et al.
European Urology
|
March 16, 2021
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021
Christian Daniel Fankhauser, Jan Oldenburg, Peter Albers, et al.
Blood
|
October 7, 2006
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation
Djordje Atanackovic, Julia Arfsten, Yanran Cao, et al.
Oncogene
|
June 2, 2018
Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option
Hauke Stamm, Felix Klingler, Eva-Maria Grossjohann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2018
SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11)
Margitta Retz, Jens Bedke, Martin Bögemann, et al.
Journal of Proteome Research
|
March 14, 2012
Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity
Sergey A Dyshlovoy, Ina Naeth, Simone Venz, et al.
World Journal of Urology
|
November 15, 2021
Therapy of clinical stage IIA and IIB seminoma: a systematic review
Julia Heinzelbecker, Stefanie Schmidt, Julia Lackner, et al.
Page
of 67
Search research articles
Search
Showing results (541-550 of 664) with videos related to
Sort By:
Page
of 67
British Journal of Haematology
|
April 16, 2022
Donor-transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation
Susanne Ghandili, Malte A Kluger, Theo Leitner, et al.
BMC Cancer
|
June 4, 2020
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)
Joseph Tintelnot, Eray Goekkurt, Mascha Binder, et al.
Marine Drugs
|
March 28, 2023
New Bioactive β-Resorcylic Acid Derivatives from the Alga-Derived Fungus <i>Penicillium antarcticum</i> KMM 4685
Elena V Leshchenko, Alexandr S Antonov, Gleb V Borkunov, et al.
The New England Journal of Medicine
|
September 12, 2008
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B Vermorken, Ricard Mesia, Fernando Rivera, et al.
European Urology
|
March 16, 2021
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021
Christian Daniel Fankhauser, Jan Oldenburg, Peter Albers, et al.
Blood
|
October 7, 2006
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation
Djordje Atanackovic, Julia Arfsten, Yanran Cao, et al.
Oncogene
|
June 2, 2018
Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option
Hauke Stamm, Felix Klingler, Eva-Maria Grossjohann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2018
SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11)
Margitta Retz, Jens Bedke, Martin Bögemann, et al.
Journal of Proteome Research
|
March 14, 2012
Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity
Sergey A Dyshlovoy, Ina Naeth, Simone Venz, et al.
World Journal of Urology
|
November 15, 2021
Therapy of clinical stage IIA and IIB seminoma: a systematic review
Julia Heinzelbecker, Stefanie Schmidt, Julia Lackner, et al.
Page
of 67